全文获取类型
收费全文 | 3420篇 |
免费 | 494篇 |
国内免费 | 3篇 |
出版年
2021年 | 48篇 |
2019年 | 29篇 |
2018年 | 36篇 |
2016年 | 66篇 |
2015年 | 115篇 |
2014年 | 126篇 |
2013年 | 136篇 |
2012年 | 173篇 |
2011年 | 170篇 |
2010年 | 112篇 |
2009年 | 97篇 |
2008年 | 134篇 |
2007年 | 153篇 |
2006年 | 115篇 |
2005年 | 127篇 |
2004年 | 118篇 |
2003年 | 124篇 |
2002年 | 106篇 |
2001年 | 110篇 |
2000年 | 93篇 |
1999年 | 98篇 |
1998年 | 42篇 |
1997年 | 31篇 |
1996年 | 40篇 |
1995年 | 41篇 |
1994年 | 37篇 |
1993年 | 37篇 |
1992年 | 79篇 |
1991年 | 81篇 |
1990年 | 75篇 |
1989年 | 63篇 |
1988年 | 60篇 |
1987年 | 49篇 |
1986年 | 53篇 |
1985年 | 64篇 |
1984年 | 47篇 |
1983年 | 57篇 |
1982年 | 51篇 |
1981年 | 31篇 |
1980年 | 32篇 |
1979年 | 53篇 |
1978年 | 35篇 |
1977年 | 38篇 |
1976年 | 36篇 |
1974年 | 37篇 |
1973年 | 42篇 |
1972年 | 32篇 |
1971年 | 39篇 |
1969年 | 27篇 |
1966年 | 35篇 |
排序方式: 共有3917条查询结果,搜索用时 187 毫秒
1.
Peter McKay 《BMJ (Clinical research ed.)》2000,320(7235):651
2.
Acetazolamide (Acz) is used at altitude to prevent acute mountain sickness, but its effect on exercise capacity under hypoxic conditions is uncertain. Nine healthy men completed this double-blind, randomized, crossover study. All subjects underwent incremental exercise to exhaustion with an inspired O(2) fraction of 0.13, hypoxic ventilatory responses, and hypercapnic ventilatory responses after Acz (500 mg twice daily for 5 doses) and placebo. Maximum power of 203 +/- 38 (SD) W on Acz was less than the placebo value of 225 +/- 40 W (P < 0.01). At peak exercise, arterialized capillary pH was lower and Po(2) higher on Acz (P < 0.01). Ventilation was 118.6 +/- 20.0 l/min at the maximal power on Acz and 102.4 +/- 20.7 l/min at the same power on placebo (P < 0.02), and Borg score for leg fatigue was increased on Acz (P < 0.02), with no difference in Borg score for dyspnea. Hypercapnic ventilatory response on Acz was greater (P < 0.02), whereas hypoxic ventilatory response was unchanged. During hypoxic exercise, Acz reduced exercise capacity associated with increased perception of leg fatigue. Despite increased ventilation, dyspnea was not increased. 相似文献
3.
4.
5.
6.
Lipoamide dehydrogenase (EC 1.6.4.3) has been isolated from a total homogenate of frozen mycelium of the thermophilic fungus Malbranchea pulchella var. sulfurea by a three-step procedure involving ammonium sulfate fractionation, Procion Brilliant Blue M-R--Sepharose 4B chromatography, and hydroxylapatite chromatography. The second step is the key purification step with the Procion Brilliant Blue M-R dye acting as an affinity ligand for the enzyme. The purified enzyme gave a single protein band on polyacrylamide gel electrophoresis in the presence and absence of sodium dodecyl sulfate. The enzyme is a dimer of molecular weight 102 000, and each monomer of 51 000 molecular weight binds one molecule of flavin adenine dinucleotide. Other properties determined include a pH optimum of 8.2, a strong specificity for the substrates dihydrolipoamide and nicotinamide adenine dinucleotide, the apparent lack of multiple enzymic forms, the presence of diaphorase activity, and resistance to temperature denaturation up to 60 degrees C. The amino acid composition and absorption spectrum of the enzyme were also determined. The properties of lipoamide dehydrogenase from this source are very similar to those reported for the enzyme from serveral other sources. 相似文献
7.
8.
Cells of the mosquito Aedes albopictus have 5.6 pg DNA/cell. This DNA is 58 mol% (A + T) and has about 0.03 mol% each of 5-methylcytosine and 6-methylaminopurine. The DNA is largely degraded by the restriction enzyme HpaII showing the virtual absence of the sequence CMeCGG. Small amounts of enzymic activity recovered largely in non-nuclear fractions transfer methyl groups from S-adenosylmethionine to cytosine and adenine. 相似文献
9.
V V Morrison G N Kryzhanovski? 《Biulleten' eksperimental'no? biologii i meditsiny》1985,100(10):445-447
The studies of survival and the life span of mice and the toxin in LD50 have shown that 4-aminopyridine (4-AP) at doses of 1, 2 and 5 mg/kg has a therapeutic effect on type C botulinic intoxication. Maximum protective effect is observed when 4-AP at a dose of 2 mg/kg is injected twice daily. Therefore, 4-AP, enhancing the transmitter release into cholinergic synapses, weakens the toxic effect of botulinic toxin. 相似文献
10.